Bedrijfsvoering Novartis AG

NOVN

CH0012005267

Farmaceutische producten

Beurs gesloten - Swiss Exchange Andere beurzen 17:30:08 15-01-2025			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
90,58 ^CHF	+0,52%		+0,21%	+2,12%

14/01	Novartis AG Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 08:15 AM
13/01	Zwitserse aandelen sluiten lager in aanloop naar belangrijke inflatie- en economische gegevens	MT

Uitvoerend comité: Novartis AG

Bedrijfsleider

Beklede functiesVan

Vasant Narasimhan

49 jaar

Chief Executive Officer

01-02-2018

Karen Hale

57 jaar

General Counsel

15-05-2021

Kees Roks

62 jaar

Comptroller/Controller/Auditor

01-05-2022

Shreeram Aradhye

63 jaar

Chief Tech/Sci/R&D Officer

16-05-2022

Robert Kowalski

57 jaar

Human Resources Officer

01-09-2021

Charlotte Pamer-Wieser

Corporate Secretary

01-09-2011

Klaus Moosmayer

57 jaar

Compliance Officer

01-12-2018

Steffen Lang

58 jaar

Chief Operating Officer

04-04-2022

Harry Werner Kirsch

60 jaar

Director of Finance/CFO

24-04-2013

Samenstelling van de raad van bestuur: Novartis AG

Directeur

RadenVan

Hans Jörg Reinhardt

69 jaar

Compensation Committee	20-04-2018
Governance Committee	21-04-2017
Nominating Committee	21-04-2017

Bridgette Heller

63 jaar

Compensation Committee Chair	13-09-2019
Audit Committee	29-06-2021
Compensation Committee	28-02-2020
Governance Committee	02-02-2021
Nominating Committee	02-02-2021
Finance Committee

Nancy Andrews

65 jaar

Governance Committee	28-02-2020
Nominating Committee	28-02-2020
Compensation Committee	01-01-2021

Patrice Bula

69 jaar

Compensation Committee	28-02-2019
Governance Committee Chair	28-02-2019
Nominating Committee Chair	28-02-2019

Simon Moroney

66 jaar

Compensation Committee Chair	28-02-2020
Compensation Committee	01-04-2021
Nominating Committee	01-04-2021

Ana de Pro Gonzalo

58 jaar

Audit Committee	04-03-2022
Compensation Committee	04-12-2021
Audit Committee Chair	01-06-2020

Daniel Hochstrasser

65 jaar

Audit Committee	04-03-2022
Governance Committee	04-03-2022
Nominating Committee	04-03-2022

John Young

61 jaar

Audit Committee
Governance Committee
Compensation Committee	18-08-2022

Frans van Houten

64 jaar

Audit Committee	02-06-2023
Governance Committee Chair	02-06-2023
Nominating Committee Chair	02-06-2023

Bill Winters

63 jaar

Compensation Committee	01-01-2013
Governance Committee	28-02-2019
Nominating Committee	28-02-2019

Charles Sawyers

66 jaar

Governance Committee	01-01-2013
Nominating Committee	01-01-2013

Liz Doherty

68 jaar

Audit Committee Chair

10-05-2019

Ton Büchner

60 jaar

Audit Committee

02-03-2018

Recente benoemingen: Novartis AG

Banzai International, Inc. Benoemt Nancy Norton tot Chief Legal Officer	18/12	CI
Maeve Waldron-Lynch treedt in dienst bij Tango Therapeutics, Inc. als Senior Vice President, Hoofd Klinische Ontwikkeling	06/11	CI
NovoCure Limited benoemt Christoph Brackmann tot Senior Financieel Adviseur	30-10-24	CI
Incannex Healthcare Inc. Kondigt de benoeming aan van Dr. Lou Barbato als Chief Medical Officer	24-10-24	CI
Kyverna Therapeutics, Inc. Kondigt wijzigingen aan in CEO	16-09-24	CI
WIJZIGINGEN IN HET MANAGEMENT: Invinity vervangt CEO; voorzitter Gulf Keystone overlijdt	06-09-24	AN
EDX Medical Group benoemt nieuwe commercieel directeur	05-09-24	MT

Meer nieuws

Voormalige zaakvoerders en bestuurders: Novartis AG

Insider

Beklede functies

VanTot

Srikant T. Madhav Datar

Director/Board Member	01-01-2003	01-01-2021
Independent Dir/Board Member	01-01-2003	01-01-2021

Pierre Landolt

Director/Board Member	08-01-2010	02-03-2018
Independent Dir/Board Member	08-01-2010	02-03-2018
Corporate Officer/Principal	01-01-1996	08-01-2010

Joseph Jimenez

Director/Board Member	02-11-2009	08-01-2010
Chief Executive Officer	01-02-2010	01-01-2018
Corporate Officer/Principal	08-01-2010	26-01-2010

Jürgen Brokatzky-Geiger

Human Resources Officer	01-01-2005	06-03-2014
Corporate Officer/Principal	06-03-2014	01-10-2017

Wendelin Wiedeking

Director/Board Member	01-01-2003	25-02-2014
Independent Dir/Board Member	01-01-2003	25-02-2014
Corporate Officer/Principal	01-01-2003	08-01-2010

Rolf M. Zinkernagel

Director/Board Member	08-01-2010	25-02-2014
Independent Dir/Board Member	01-01-1999	25-02-2014
Corporate Officer/Principal	01-01-1999	08-01-2010

Alexandre F. Jetzer-Chung

Director/Board Member	08-01-2010	22-02-2011
Corporate Officer/Principal	01-01-1996	08-01-2010

Raymund Breu

Director of Finance/CFO

01-12-1996

01-01-2009

William Brody

Director/Board Member	24-02-2009	-
Independent Dir/Board Member	25-08-2011	-

Urs Bärlocher

General Counsel

01-01-1999

31-08-2007

Thomas Ebeling

Corporate Officer/Principal

01-01-2000

01-01-2007

Andreas von Planta

Director/Board Member	01-01-2006	-
Independent Dir/Board Member	01-01-2006	-

Karen Hübscher

Public Communications Contact

01-01-2000

01-01-2006

Pierre F. Dodion

Sales & Marketing

01-01-2002

01-01-2006

François Martelet

Corporate Officer/Principal

01-07-2003

01-07-2005

Ian Garland

Corporate Officer/Principal

01-06-2005

Joachim P. H. Schupp

Corporate Officer/Principal

01-01-1985

01-10-2004

Ronen Tamir

Investor Relations Contact	28-10-2011	-
Public Communications Contact	28-10-2011	-
Corporate Officer/Principal	01-01-2004	28-10-2011

Marshall E. Reese

Corporate Officer/Principal

01-01-1999

01-01-2004

Gilbert Wenzel

Corporate Officer/Principal

01-11-2000

01-01-2003

Mihael Polymeropoulos

Corporate Officer/Principal

01-01-1998

01-01-2003

Paul Herrling

Chief Tech/Sci/R&D Officer

01-11-2002

Bruce F. Fleming

Corporate Officer/Principal

01-06-2001

01-06-2002

Silke Zentner

Public Communications Contact

05-04-2002

Paolo Baroldi

Corporate Officer/Principal

01-01-1998

01-01-2002

Fredrik Ollila

Corporate Officer/Principal

01-01-2002

James New

Corporate Officer/Principal

01-01-1999

Norman Hardman

Chief Tech/Sci/R&D Officer

01-01-1996

Peter Burckhardt

Director/Board Member	31-12-2009	-
Corporate Officer/Principal	01-01-1996	31-12-2009

Birgit Breuel

Corporate Officer/Principal

01-01-1996

Helmut Sihler

Director/Board Member

01-01-1996

John McKenna

Corporate Officer/Principal

01-01-1990

Ann Bailey

Public Communications Contact

01-01-1982

Gabor Veres

Corporate Officer/Principal

Michael Horne

Corporate Officer/Principal

David Metzger

Corporate Officer/Principal

John H. van Duzer

Corporate Officer/Principal

MaryAnn DeMarco

Corporate Officer/Principal

John McAdoo

Corporate Officer/Principal

Ian Stuart Charles Talmage

Corporate Officer/Principal

Geoff MacKay

Corporate Officer/Principal

Jutta Monika Heim

Corporate Officer/Principal

Peter Thomas Sany

Chief Tech/Sci/R&D Officer

Ian Matthews

Corporate Officer/Principal

Siv Lindbratt Börjes

Corporate Officer/Principal

Bobby Singh

Corporate Officer/Principal

Ann Moravick

Corporate Officer/Principal

Nagesh Mahanthappa

Corporate Officer/Principal

William P. Keane

Corporate Officer/Principal

Max Burger

Chairman	21-04-2010	-
President	17-07-2009	21-04-2010

Virginia Jamieson

Corporate Officer/Principal

Humphrey Harte

Corporate Officer/Principal

Roland M. Jeannet

Corporate Officer/Principal

Adrian Hunter

Corporate Officer/Principal

Rob Goshert

Corporate Officer/Principal

Dominique Cheneval

Corporate Officer/Principal

Christoph Hüls

Corporate Officer/Principal

Ingrid Duplain

Corporate Secretary

Bruno Heynen

Corporate Secretary

Corinne Hoff

Public Communications Contact

Stuart J. Davie

Chief Tech/Sci/R&D Officer

Günter Frankenne

Director/Board Member

Karel Petrak

Corporate Officer/Principal

Peter E. Carlin

Corporate Officer/Principal

Terry Hart

Corporate Officer/Principal

Geert C. Mudde

Corporate Officer/Principal

Phil Johnson

Corporate Officer/Principal

Malcolm B. Cheetham

Comptroller/Controller/Auditor

James Phillips

Corporate Officer/Principal

Eric Wayne Evans

Director of Finance/CFO

Armin M. Kessler

Sales & Marketing

Hans-Georg Capraro

Corporate Officer/Principal

William J. Rutter

Director/Board Member

Gordon Wright

Corporate Officer/Principal

Randall S. Moore

Corporate Officer/Principal

Jeret Bode

Corporate Officer/Principal

Jeffrey Hrkach

Corporate Officer/Principal

Peter Herold

Corporate Officer/Principal

Thomas Littke

Corporate Officer/Principal

John Slevin

Corporate Officer/Principal

Cees Winnips

Corporate Officer/Principal

Maike July-Grolman

Corporate Officer/Principal

Ruth Metzler-Arnold

Public Communications Contact

28-07-2009

Leeftijdsdistributie van bedrijfsleiders

Ratio vrouwen/mannen

Man	25
Vrouw	6

Waarvan leden van het uitvoerend comité

Man	8
Vrouw	1

Waarvan bestuurders

Man	10
Vrouw	3

ESG MSCI

ESG

Milieu

Sociaal

Bedrijfsvoering

Controverse

Novartis AG is een van 's werelds leiders op het gebied van het ontwerpen, produceren en op de markt brengen van farmaceutische producten. De netto-omzet (exclusief beëindigde bedrijfsactiviteiten) kan als volgt worden uitgesplitst naar therapeutisch gebied - oncologie (29,9%) - immunologie (17,2%) - cardiovasculaire, nier- en metabolische ziekten (14,1%); - neurowetenschap (8,9%). De resterende netto-omzet (29,9%) is afkomstig van contractproductie van farmaceutische producten. Eind 2023 had Novartis AG wereldwijd 33 productielocaties. De netto-omzet is geografisch als volgt verdeeld: Europa (33%), de Verenigde Staten (39,5%), Azië/Afrika/Australië (20,5%), Canada en Latijns-Amerika (7%).

Werknemers

76.057

Sector

Farmaceutische producten

Agenda

31-01-2025 - Q4 2024 Cijferpublicaties

Meer informatie over het bedrijf